keyword
MENU ▼
Read by QxMD icon Read
search

Multiple Scerosis

keyword
https://www.readbyqxmd.com/read/25891598/effect-of-natalizumab-on-clinical-radiological-disease-activity-and-edss-of-relapsing-remitting-multiple-sclerosis-patients
#1
M Agiela
INTRODUCTION: Natalizumab is a humanized monoclonal antibody that blocks T-cell transmigration through the blood-brain barrier into CNS. OBJECTIVE: AFFIRM showed monotherapy with Natalizumab for 2 year reduced the annualized relapse rate ARR by 68% and the disability progression rate by 42%. This is our first experince in use of Natalizumab in Benghazi-Libya. So we want to evalute its efficacy. METHODS: Four patients of relapsing remitting multiple scerosis on Natalizumab (JC virus negative and MRI prior to use drug done) followed in our clinical practice regarding frequency of relapse, EDSS and new T2-hyperintense lesion on MRI for 24 months for 3 patients and 1 ptient for 12 months...
November 2014: Multiple Sclerosis and related Disorders
https://www.readbyqxmd.com/read/19809964/-fingolimod-a-new-immunomodulator
#2
REVIEW
F W Friedrich, T Eschenhagen
Fingolimod is a derivative of the naturally occurring immunosuppressive substance myriocin, with structural similarity to sphingosine, a ubiquitous sphingolipid. It acts as an immunomodulator interfering with the egress of T and B lymphocytes from secondary lymph organs, which results in lymphopenia. A phase II study in patients with multiple scerosis showed a significant reduction in annual relapse rate and lesions in magnetic resonance imaging with an acceptable rate of side effects. An advantage of fingolimod compared to interferon beta, glatirameracetate and natalizumab is its oral availability...
October 2009: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/1035520/-present-status-of-clinical-neurology-in-japan-1-epidemiological-and-clinical-studies-on-multiple-scerosis-in-japan-and-asia
#3
Y Kuroiwa
No abstract text is available yet for this article.
December 1976: Rinshō Shinkeigaku, Clinical Neurology
https://www.readbyqxmd.com/read/51672/the-localization-of-the-basic-protein-and-n-2-in-diseased-myelin
#4
D D Wood, W J Vail, M A Moscarello
A non-penetrating reagent 4,4'-diisothiocyano-2,2'-ditritiostilbene disulfonic acid ([3H]DIDS) has been used to label isolated normal and diseased myelin. The basic protein and the hydrophobic protein, N-2, were isolated from each myelin. When normal myelin was labeled the specific activity of the basic protein was about 25% of that of the hydrophobic protein (N-2). The specific activities of these two proteins isolated from chronic multiple sclerosis myelin were similar to those of the normal myelin. In contrast, the specific acitivity of the basic protein isolated from acute multiple sclerosis myelin was about 400% higher than that of the basic protein isolated from either normal or chronic multiple sclerosis myelins...
August 15, 1975: Brain Research
https://www.readbyqxmd.com/read/50571/-serologic-tests-with-the-use-of-encephalitogenic-protein-in-the-diagnosis-of-multiple-scerosis
#5
A Wajgt, L Torliński, U Chmielewska
No abstract text is available yet for this article.
March 1975: Neurologia i Neurochirurgia Polska
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"